Each marker represents a country-specific estimate of discounted incremental DALYs averted per person (ie, per household contact or PLWHA) from implementing 3HP (x axis) and corresponding discounted incremental costs (y axis), compared with a scenario of no TPT for household contacts younger than 5 years. Both x and y axes are on a log scale. Countries are labelled by their 3-digit ISO codes (positions of country code labels have been jittered to avoid overlaps), and population-weighted means across the 29 countries are designated via a white star. Shaded areas indicate incremental cost-effectiveness ratios. For example, in B, the plot indicates that the incremental cost-effectiveness ratio of 3HP for contacts aged 514 years in ZAF is between $100 and $500 per DALY averted, and in D, the plot indicates that the incremental cost-effectiveness ratio of tuberculosis preventive treatment for PLWHA in ZAF is between $500 and $1000 per DALY averted. Cambodia, Eswatini, Mongolia, and Namibia are omitted from panel D because scaling up 3HP for PLWHA in these countries was estimated to be cost saving; there were no countries for which the intervention was cost saving in the other analyses presented in AC. Values and cost-effectiveness thresholds for each country are in theappendix (pp 5658). 3HP=12 weeks of isoniazid and rifapentine. DALY=disability-adjusted life year. PLWHA=people living with HIV/AIDS. BDI=Burundi. BGD=Bangladesh. BRA=Brazil. COD=DR Congo. ETH=Ethiopia. GHA=Ghana. HTI=Haiti. IDN=Indonesia. IND=India. KEN=Kenya. KHM=Cambodia. LBR=Liberia. LSO=Lesotho. MNG=Mongolia. MOZ=Mozambique. MWI=Malawi. NAM=Namibia. PAK=Pakistan. RWA=Rwanda. SOM=Somalia. SWZ=Eswatini. THA=Thailand. TJK=Tajikistan. TLS=Timor-Leste. TZA=Tanzania. UGA=Uganda. ZAF=South Africa. ZMB=Zambia. ZWE=Zimbabwe.